◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › Q › QDEL

Quidel Corporation (QDEL) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-18

Quidel Corporation (QDEL) operates in the MEDICAL DEVICES industry and is headquartered in San Diego, United States with about 6,500 employees. Its market capitalization is roughly $728 million. In the fiscal year ended 2025-12-31, QDEL reported $2.7B in revenue and ($1.1B) in net income.

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.

Interactive charts & full statements → Open the QDEL valuation workbench →

QDEL Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$2.7B	$2.7B	$2.8B	$3.0B	$3.3B	$1.7B	$1.7B	$535M	$522M	$278M	$192M	$196M	$183M	$175M	$156M	$159M	$113M	$164M	$128M	$118M	$106M
Gross Profit	$1.2B	$1.3B	$1.3B	$1.5B	$1.9B	$1.3B	$1.3B	$321M	$316M	$156M	$118M	$124M	$108M	$108M	$94M	$96M	$61M	$109M	$78M	$69M	$61M
Gross Margin %	44.6%	46.7%	46.2%	49.9%	59.3%	75.3%	81.2%	60.0%	60.5%	56.2%	61.7%	63.4%	59.4%	61.8%	60.7%	60.4%	53.6%	66.4%	60.8%	58.9%	57.7%
Operating Income (EBIT)	($820M)	($919M)	($2.0B)	$139M	$844M	$906M	$1.1B	$93M	$96M	$10M	($4M)	$3M	($9M)	$4M	$9M	$14M	($15M)	$53M	$29M	$19M	$14M
Operating Margin %	-30.7%	-33.7%	-70.5%	4.6%	25.8%	53.3%	63.8%	17.3%	18.4%	3.4%	-2.3%	1.4%	-5.0%	2.4%	5.7%	8.7%	-13.5%	32.0%	22.3%	16.5%	13.1%
Net Income	($1.0B)	($1.1B)	($2.1B)	($10M)	$549M	$704M	$810M	$73M	$74M	($8M)	($14M)	($6M)	($7M)	$7M	$5M	$8M	($11M)	$33M	$19M	$14M	$22M
Net Margin %	-39.2%	-41.4%	-73.7%	-0.3%	16.8%	41.5%	48.8%	13.6%	14.2%	-2.9%	-7.2%	-3.1%	-3.9%	4.2%	3.2%	4.8%	-9.9%	20.0%	14.7%	11.6%	20.5%
EBITDA	($499M)	($488M)	($1.5B)	$607M	$1.1B	$953M	$1.1B	$140M	$134M	$40M	$19M	$12M	$19M	$30M	$16M	$31M	($3M)	$59M	$39M	$31M	$23M
Earnings Per Share (EPS)	$-15.41	$-16.69	$-30.54	$-0.15	$9.56	$16.42	$18.59	$1.69	$1.74	$-0.24	$-0.42	$-0.18	$-0.21	$0.21	$0.15	$0.23	$-0.39	$1.08	$0.58	$0.41	$0.63
Shares Outstanding (M)	68M	68M	67M	67M	57M	43M	44M	43M	43M	34M	33M	34M	34M	35M	34M	33M	29M	30M	33M	33M	34M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

QDEL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$631M	$620M	$724M	$700M	$614M	$693M	$708M	$727M
Gross Profit	$273M	$264M	$320M	$336M	$275M	$343M	$326M	$352M
Gross Margin %	43.3%	42.6%	44.3%	47.9%	44.8%	49.5%	46.1%	48.4%
Operating Income (EBIT)	($22M)	($27M)	($66M)	($705M)	($181M)	$33M	($100M)	$15M
Operating Margin %	-3.5%	-4.4%	-9.2%	-100.7%	-29.4%	4.7%	-14.2%	2.1%
Net Income	($93M)	($92M)	($131M)	($733M)	($255M)	($13M)	($178M)	($20M)
Net Margin %	-14.7%	-14.8%	-18.1%	-104.7%	-41.6%	-1.8%	-25.2%	-2.7%
EBITDA	($26M)	$81M	$43M	($597M)	($76M)	$141M	$13M	$134M
Earnings Per Share (EPS)	$-1.36	$-1.35	$-1.93	$-10.78	$-3.77	$-0.19	$-2.65	$-0.30
Shares Outstanding (M)	68M	68M	68M	68M	68M	68M	67M	67M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

QDEL Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	($57M)	$105M	$83M	$280M	$885M	$806M	$630M	$134M	$136M	$28M	$12M	$36M	$36M	$26M	$20M	$47M	($10M)	$73M	$29M	$27M	$21M
Capital Expenditures (CapEx)	$154M	$188M	$195M	$209M	$141M	$293M	$65M	$27M	$32M	$18M	$12M	$17M	$11M	$23M	$28M	$21M	$10M	$7M	$4M	$4M	$11M
Free Cash Flow (FCF)	($211M)	($83M)	($112M)	$71M	$744M	$513M	$565M	$107M	$105M	$10M	$0M	$19M	$24M	$3M	($8M)	$26M	($21M)	$66M	$24M	$24M	$10M
FCF Margin %	-7.9%	-3.0%	-4.0%	2.4%	22.8%	30.2%	34.0%	20.1%	20.0%	3.7%	-0.1%	9.8%	13.4%	1.8%	-5.2%	16.5%	-18.3%	40.0%	19.1%	20.0%	9.2%
Dividends Paid	—	—	—	—	—	—	—	—	—	$255M	$0M	$0M	$172M	$0M	$0M	$0M	$75M	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

QDEL Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($111M)	($33M)	$132M	($46M)	($47M)	$66M	$64M	$118M
Capital Expenditures (CapEx)	$26M	$34M	$45M	$49M	$6M	$10M	$47M	$46M
Free Cash Flow (FCF)	($136M)	($67M)	$87M	($95M)	($53M)	$56M	$16M	$71M
FCF Margin %	-21.6%	-10.8%	12.0%	-13.5%	-8.7%	8.0%	2.3%	9.8%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

QDEL Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$5.7B	$5.8B	$6.4B	$8.6B	$8.9B	$2.4B	$1.9B	$911M	$806M	$935M	$388M	$407M	$447M	$271M	$242M	$279M	$215M	$166M	$143M	$134M	$127M
Cash & Cash Equivalents	$123M	$170M	$98M	$119M	$293M	$803M	$490M	$53M	$44M	$36M	$170M	$191M	$201M	$8M	$15M	$61M	$7M	$89M	$58M	$45M	$37M
Total Liabilities	$3.9B	$3.8B	$3.4B	$3.6B	$3.9B	$501M	$538M	$351M	$381M	$708M	$188M	$188M	$202M	$48M	$42M	$94M	$102M	$40M	$24M	$26M	$24M
Total Debt (Short + Long-Term)	$2.9B	$2.7B	$2.5B	$2.4B	$2.7B	$11M	$8M	$19M	$108M	$397M	$144M	$144M	$143M	$6M	$5M	$42M	$80M	$7M	$7M	$9M	$8M
Total Shareholders' Equity	$1.8B	$1.9B	$3.0B	$5.0B	$4.9B	$1.9B	$1.3B	$560M	$426M	$227M	$201M	$219M	$245M	$224M	$200M	$185M	$113M	$126M	$119M	$108M	$103M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive QDEL viewer.

Other Companies in MEDICAL DEVICES

SIBN · Si-Bone Inc — $824 million
AVR · Anteris Technologies Global Corp. Common Stock — $809 million
VREX · Varex Imaging Corp — $779 million
AHCO · Adapthealth Corp — $760 million
PHG · Koninklijke Philips NV ADR — $24 billion
PEN · Penumbra Inc — $13 billion
SNN · Smith & Nephew SNATS Inc — $12 billion
BIO · Bio-Rad Laboratories Inc — $10 billion

← QDEF All “Q” companies QDEV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.